| A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes MA Niewczas, ME Pavkov, J Skupien, A Smiles, ZI Md Dom, JM Wilson, ... Nature medicine 25 (5), 805-813, 2019 | 300 | 2019 |
| Residual β cell function and monogenic variants in long-duration type 1 diabetes patients MG Yu, HA Keenan, HS Shah, SG Frodsham, D Pober, Z He, EA Wolfson, ... The Journal of clinical investigation 129 (8), 3252-3263, 2019 | 84 | 2019 |
| Characterization of glycolytic enzymes and pyruvate kinase M2 in type 1 and 2 diabetic nephropathy D Gordin, H Shah, T Shinjo, R St-Louis, W Qi, K Park, SM Paniagua, ... Diabetes care 42 (7), 1263-1273, 2019 | 75 | 2019 |
| Genetic predictors of cardiovascular mortality during intensive glycemic control in type 2 diabetes: findings from the ACCORD clinical trial HS Shah, H Gao, ML Morieri, J Skupien, S Marvel, G Paré, GC Mannino, ... Diabetes Care 39 (11), 1915-1924, 2016 | 52 | 2016 |
| Variants inangptl4and the Risk of Coronary Artery Disease AD Morieri, Mario L., Hetal Shah The New England Journal of Medicine 375 (23), 2304-2305, 2016 | 51* | 2016 |
| Genetic variants in CPA6 and PRPF31 are associated with variation in response to metformin in individuals with type 2 diabetes DM Rotroff, SW Yee, K Zhou, SW Marvel, HS Shah, JR Jack, TM Havener, ... Diabetes 67 (7), 1428-1440, 2018 | 45 | 2018 |
| Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes DM Rotroff, SS Pijut, SW Marvel, JR Jack, TM Havener, A Pujol, ... Clinical Pharmacology & Therapeutics 103 (4), 712-721, 2018 | 45 | 2018 |
| Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD trial Y Tang, H Shah, CR Bueno Junior, X Sun, J Mitri, M Sambataro, ... Diabetes Care 44 (1), 164-173, 2021 | 43 | 2021 |
| High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 … T Vaisar, JE Kanter, J Wimberger, AD Irwin, J Gauthier, E Wolfson, ... Diabetes Care 43 (1), 178-186, 2020 | 42 | 2020 |
| Diabetes mellitus correlates with increased biological age as indicated by clinical biomarkers N Bahour, B Cortez, H Pan, H Shah, A Doria, C Aguayo-Mazzucato Geroscience, 1-13, 2022 | 40 | 2022 |
| Genetic tools for coronary risk assessment in type 2 diabetes: a cohort study from the ACCORD clinical trial ML Morieri, H Gao, M Pigeyre, HS Shah, J Sjaarda, C Mendonca, ... Diabetes Care 41 (11), 2404-2413, 2018 | 36 | 2018 |
| The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects R Sharma, S Prudente, F Andreozzi, C Powers, G Mannino, S Bacci, ... Atherosclerosis 216 (1), 157-160, 2011 | 36 | 2011 |
| PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid ML Morieri, HS Shah, J Sjaarda, PA Lenzini, H Campbell, ... Diabetes 69 (4), 771-783, 2020 | 32 | 2020 |
| A genetic locus on chromosome 2q24 predicting peripheral neuropathy risk in type 2 diabetes: results from the ACCORD and BARI 2D studies Y Tang, PA Lenzini, R Pop-Busui, PR Ray, H Campbell, BA Perkins, ... Diabetes 68 (8), 1649-1662, 2019 | 30 | 2019 |
| Genetic variant at the GLUL locus predicts all-cause mortality in patients with type 2 diabetes S Prudente, H Shah, D Bailetti, M Pezzolesi, P Buranasupkajorn, ... Diabetes 64 (7), 2658-2663, 2015 | 29 | 2015 |
| Characterization of periodontitis in people with type 1 diabetes of 50 years or longer duration T Shinjo, A Ishikado, H Hasturk, DM Pober, SM Paniagua, H Shah, IH Wu, ... Journal of periodontology 90 (6), 565-575, 2019 | 28 | 2019 |
| Modulation of GLP-1 levels by a genetic variant that regulates the cardiovascular effects of intensive glycemic control in ACCORD HS Shah, ML Morieri, SM Marcovina, RJ Sigal, HC Gerstein, MJ Wagner, ... Diabetes Care 41 (2), 348-355, 2018 | 23 | 2018 |
| Association of cognitive function and retinal neural and vascular structure in type 1 diabetes W Fickweiler, EA Wolfson, SM Paniagua, MG Yu, A Adam, V Bahnam, ... The Journal of Clinical Endocrinology & Metabolism 106 (4), e1139-e1149, 2021 | 21 | 2021 |
| Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis S Prudente, E Morini, L Marselli, R Baratta, M Copetti, C Mendonca, ... The Journal of Clinical Endocrinology & Metabolism 98 (6), E1143-E1147, 2013 | 20 | 2013 |
| Estimation of mortality risk in type 2 diabetic patients (enforce): an inexpensive and parsimonious prediction model M Copetti, H Shah, A Fontana, MG Scarale, C Menzaghi, S De Cosmo, ... The Journal of Clinical Endocrinology & Metabolism 104 (10), 4900-4908, 2019 | 19 | 2019 |
